Background. Fetal growth restriction (FGR) is an unclearly defined condition described as a fetal weight which is too low in relation to gestational age. It is recognized in 10-15% of singleton pregnancies and can lead to severe complications, including stillbirth. To reduce the adverse fetal and neonatal outcomes, many medical interventions are being introduced by obstetricians. These, like all medical procedures, may induce further complications, such as preterm labor and its consequences.
Introduction
Fetal growth restriction (FGR) is a condition unclearly defined as a fetal weight which is too low in relation to gestational age. Different kinds of FGR appear in 5-10% of all pregnancies. 1 This multitude of forms is due to different definitions based on diverse diagnostic criteria. Fetal hypotrophy is synonymous with a small fetus which did not fully realize its growth potential. Other disorders, such as ''small for gestational age" (SGA) and ''intrauterine growth restriction" (IUGR) are diagnosed by ultrasound examination during the 2 nd and 3 rd trimester of pregnancy. Small for gestational age is defined as estimated fetal weight (EFW) below the 10 th percentile in ultrasound examination using a software program which calculates the fetal weight on the basis of particular parameters. 2 The definition of IUGR is the same as SGA, but there is an additional requirement to evaluate impaired Doppler flows in the umbilical artery or in the medium cerebral artery.
All types of FGR are associated with severe complications, which are a challenge and a substantial problem for contemporary perinatology. The causes of SGA can be constitutional determinants or various pathological factors, but typically a combination of several of them leads to fetal hypotrophy. 3 Fetal growth restriction is associated with an increased risk of adverse perinatal outcomes, especially stillbirth, preterm delivery, intrauterine hypoxia, cerebral palsy, and other complications in late childhood, as well as lower IQ scores in young adults. 4, 5 Thus, every patient with suspected fetal hypotrophy should be monitored under professional obstetric care.
The problem becomes more complex when regarding the opinions of scientific committees about the standards of management in patients with suspected SGA fetuses. A lack of medical interventions with proven effectiveness, which could stop or reverse the development of FGR, render appropriate perinatal care to be the only therapeutic option. However, there is no unanimity among European and American societies concerning the time and method of delivery. According to the guidelines set forth by the Royal College of Obstetricians and Gynecologists, the essential parameters deciding about the best management are umbilical Dopplers. In fetuses with inappropriate umbilical artery flows (absent or reversed end-diastolic velocity), the committee recommends delivery by cesarean section, while induced labor may be offered to those with normal umbilical artery Doppler flows (with level B evidence). 6 Canadians suggest that if a pregnancy lasts longer than 37 weeks, the obstetrician should consider the choice between expectant management with close fetal/maternal surveillance and delivery. When undertaking clinical interventions, such as cesarean section, ultrasound assessment is a useful tool in evaluating fetal viability. 7 On the other hand, the American College of Obstetricians and Gynecologists cites the results from trials such as the Growth Restriction Intervention Trial (GRIT) and the Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT), which proved no benefit or harm caused by immediate delivery. 8 According to the Polish Gynecological Society's guidelines, induced labor is recommended in such cases. 9 There is research proving that SGA recognized antenatally implicates more frequent obstetric interventions, without a significant positive impact on early neonatal outcomes. 10
Objectives
The study aimed to assess different kinds of management (expectant monitoring, induction or elective cesarean section -ECS) in pregnancies with suspected SGA fetuses in the context of perinatal outcomes and neonatal complications. The other purpose was to determine the specificity of ultrasound examination in recognizing SGA.
Material and methods
This retrospective single-center study was carried out in the 1 st Department of Obstetrics and Gynecology at the Medical University of Warsaw, Poland. Data regarding the baseline characteristics of patients and the course of gestation was obtained from archival medical documentation of hospitalizations during the last pregnancy. The inclusion criteria were women in singleton pregnancies suspected of fetal hypotrophy or SGA who delivered in the 25 th -41 st week of gestation between January 1, 2013 and December 31, 2014. The exclusion criteria were insufficient or incomplete medical history (usually associated with missing ultrasound scans), women in multiple pregnancies and fetuses with chromosomal abnormalities. The study group consisted of 146 patients, according to the abovementioned criteria.
The authors also evaluated the following complications during pregnancy: gestational hypertension, preeclampsia, diabetes, oligohydramnios (defined as an amniotic fluid index -AFI <5 cm after summing up the measurements of the largest fluid pockets from each of the 4 uterine quadrants), and obesity (body mass index -BMI ≥30 kg/m 2 ). [11] [12] [13] Other parameters, such as maternal age, parity and smoking during pregnancy, were also taken into consideration. The authors also carefully took into account complications in previous pregnancies -especially stillbirth, IUGR and preeclampsia.
The study group comprised 146 women in singleton pregnancies with suspected SGA. Small for gestational age was defined as a fetus with EFW below the 10 th percentile for adequate gestational age, using standard population-based centile charts. Estimated fetal weight was assessed through ultrasound examination during the 3 rd trimester, based on the following biometric measurements: bi-parietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL), using the Hadlock-1 formula (BPD + HC + AC + FL) developed by Professor Kypros Nicolaides. Many research studies have proven the utility of this formula with a high positive correlation between EFW and actual birth weight. 14, 15 Also, in comparison with other available patterns, it seems to have the highest predictive value. 16 The authors took into account only the outcome of the recent ultrasound examination which confirmed SGA. Each ultrasound examination was carried out at the hospital ultrasonography station, using high-quality ultrasound systems with a curvilinear array real-time system and a 3.5 or 5.0 MHz transducer.
From the cohort of 146 patients with suspected SGA fetuses, the authors retrospectively selected a group of patients with hypotrophy of the fetuses confirmed after delivery, hereafter called group A. Neonatal hypotrophy was defined as a newborn's birth weight below the 10 th percentile for the appropriate week of delivery, sex and population. Patients with false positive diagnosis of SGA, unconfirmed after delivery, were classified as group B.
Both groups were compared between each other with regard to the average duration of gestation, the percentage of preterm births, the mother's age, BMI, and parity -and in the cases of multiparous women, the time since the previous pregnancy. All patients were of Caucasian ethnicity.
Patients from the study group were evaluated for the mode of delivery, medical procedures undertaken during pregnancy and perinatal complications. The authors assessed whether women from the study group had indications for induced labor or ECS, and what influence these procedures had on the maternal and neonatal outcomes. Adverse neonatal outcomes were defined as death before hospital discharge, a 5-minute Apgar score <7 and admission to the neonatal intensive care unit (NICU). In perinatal complications, the authors also evaluated the length of stay at the NICU or the neonatal ward, respiratory disorders, sepsis, hypoglycemia, and intraventricular hemorrhage.
The outcomes were analyzed with regard to double cutoff thresholds for both the study group and the control group: <10 th -3 rd percentile and <3 rd percentile.
Statistical analysis was performed with the Mann-Whitney U test for qualitative values and the Fisher's exact test in the case of quantitative references. P-values <0.05 were considered significant. For a statistical evaluation of the results obtained, the authors used the Statistical Analysis Statement program (SAS/STAT ® v. 14.1 Software, SAS Institute Inc., Cary, USA).
Results
Sixty-five newborns suspected of being SGA antenatally by ultrasound examination had a birth weight below the 10 th percentile, which represents 44.5% of the sample size. Eighty-one patients (55.5%) were not confirmed as SGA after delivery (later defined as group B). The accordingly positive predictive value of ultrasound examination in the recognition of SGA was estimated at 44.5%. Within group A, the mean age of the mothers equaled 32.5 years (±5.05) and was significantly higher than the mean age within group B, which was 29.5 years (±5.69) (p = 0.0015). The percentage of primiparous women was lower among patients whose newborns were diagnosed as SGA after birth, but without statistical significance (62% vs 74% in group B; p = 1.0). When it comes to multiparous women, the time elapsed since their last pregnancy was similar in both groups (1.74 ±4.89 years vs 1.72 ±2.83 years in groups A and B, respectively; p = 0.3496).
The average duration of pregnancy was lower among patients from the 1 st group and equaled 34.9 ±3.80 weeks, in comparison to 36.9 ±2.55 weeks in the 2 nd one (p = 0.0317).
Among all mothers, 58.9% delivered between the 37 th and the 41 st week of pregnancy, 40.4% before the 37 th week and 0.7% of the pregnancies lasted over 41 weeks. Late-preterm deliveries (between the 34 th and the 36 th week) made up 23.3% of all pregnancies, while early-preterm (before the 34 th week) constituted 17.1% of the sample size. The full characteristics of patients are presented in Table 1 .
The average BMI value at the beginning of the pregnancy was 23.38 ±4.38 kg/m² in patients with SGA confirmed after delivery, while in group B, the mean BMI was 21.97 ±4.26 kg/m². A retrospective analysis evaluating BMI values in comparison with a positive predictive value of SGA recognition during antenatal ultrasound examination was also conducted. Patients from the study group were divided into 3 subgroups depending on BMI values, namely: <18.5 kg/m², between 18.5 kg/m 2 and 25 kg/m 2 , and >25 kg/m 2 ( Table 2 ). Maternal underweight (BMI <18.5 kg/m²) correlated with only an 11% positive predictive value of SGA recognition in ultrasound examination (p = 0.0051). The results obtained show that up to 89% of pregnancies were overdiagnosed and that in that group, the standard methods of SGA recognition are less efficient. The percentage of confirmed SGA fetuses after birth was similar in women with normal weight (BMI of between 18.5 kg/m 2 and 25 kg/m²) and those who were obese before pregnancy (BMI >25 kg/m²), and it amounted to 49% and 46%, respectively. Body mass index evaluated in the last trimester of pregnancy had no significant influence on the detection of SGA babies.
Among all patients, 59 gestations were complicated, with preterm delivery. In that group, 42.4% of samples (25) were classified as early preterm (defined as labor between the 22 nd and the 34 th week of gestation), while 57.6% (34) were late preterm deliveries (between weeks 35 and 37). With a view to generating more precise results, we decided to isolate a group of severe hypotrophy with EFW below the 3 rd percentile. In the 1 st group, 84% of newborns were classified below the 3 rd percentile after birth and 16% of them were between the 3 rd and 9.9 th percentile. In the case of late preterm delivery, the percentage of newborns below the 3 rd percentile was lower than in the previous group and amounted to 53%, while 47% of them gained in birth weight from the 3 rd to the 9.9 th percentile.
Patients who underwent iatrogenic procedures comprised 86.3% of all pregnancies (126). Up to 43% (54) of those pregnancies were ended by ECS and 57% (72) by induced labor. Induced deliveries ended with ECS in 23.6% of cases. Of all deliveries, 13.7% (20) began spontaneously, where 65% (13) were managed by vaginal delivery and 35% (7) required cesarean section. The most frequently isolated medical indication for induced labor was fetal hypotrophy (about 50%). In 37.5% of all patients, the suspicion of SGA occurred together with several other indications, such as post-term pregnancy, oligohydramnios, gestational diabetes mellitus, pregnancy-induced hypertension, and abnormalities in a non-stress test. Only 12.5% of all cases were associated with indications other than fetus hypotrophy, e.g., preeclampsia or preterm rupture of membranes.
The most severe complication -intrauterine death -occurred in 2 cases in group A (3% of the sample), while it was not reported among group B. The risk of intrauterine death did not significantly correlate with any pathologies during the course of pregnancy, including IUGR (p = 0.196).
In each case, the prenatal diagnosis of SGA was confirmed after delivery with a neonatal birth weight below the 1 st percentile (418 g and 880 g). Both of those pregnancies ended with vaginal delivery, the 1 st one spontaneously in the 27 th week, while the 2 nd one ended after induction and steroid therapy in the 31 st week of pregnancy due to the threat of asphyxia.
In total, 78 pregnancies ended with cesarean section -in 69% as an elective procedure, in 22% after an unsuccessful induction and in 9% following a spontaneously begun delivery. Most of them were associated with the following indications: imminent fetal asphyxia, fetal hypotrophy, abnormal outcome of a non-stress test, failed induction, and breech position or preeclampsia.
The Apgar score, the simplest and most reliable method of evaluation, was performed to assess the general condition of newborn babies suspected of being SGA. We observed significantly worse perinatal outcomes in the group with confirmed severe hypotrophy (below the 3 rd percentile). Of those newborns, 17.6% scored <7 points and 8.8% scored <3 points in the Apgar score in the 1 st minute, while only 4.5% of the infants between the 3 rd and 9.9 th percentile in weight scored <7 points (p = 0.0213).
For 13 newborns from the output cohort, medical documentation was unavailable, which is why the following outcomes regard a smaller sample size than before, 59 samples with confirmed hypotrophy (group A) and 74 without confirmation after delivery (group B).
Serious complications in the early neonatal period, e.g., respiratory disorders, cardiovascular insufficiency, intraventricular hemorrhage, or neonatal deaths, occurred in 34% (45) of all newborns whose medical history was available, and separating that data, in 46% and 19% of samples from groups A and B, respectively.
Elective cesarean section was performed in 68.4% of patients from group A and in 63.2% of group B patients, respectively; induced labor was executed in 10.5% of patients from group A and in 21.1% from group B.
Newborns with confirmed hypotrophy were more often admitted to the NICU after birth (32.2% vs 23%; p =0.0253) and significantly more frequently suffered from cardiovascular insufficiency (18.6% vs 2.7%; p = 0.0027). Moreover, children from group A more often required invasive procedures, such as synchronized intermittent mandatory ventilation (SIMV) (18.6% vs 5.4%; p = 0.0253). We reported 6 neonatal deaths after delivery in group A (10.2%), while that complication was not observed among any neonates with an unconfirmed diagnosis of SGA (p = 0.0066). More details concerning severe neonatal complications are presented in Table 3 .
The complications which occurred in the remaining newborns, such as intraventricular hemorrhage, early infections and hypoglycemia, did not demonstrate any statistically significant correlations. The average duration of hospitalization was similar in both groups (8.67 ±9.81 days vs 7.86 ±8.80 days; p = 0.2365). Hospitalization at the NICU was required in 8% and 8.5% of newborns after induced labor (p = 0.6726), in 45% and 48% of those delivered by ECS (p = 0.5083), and in 36% and 33% of children after spontaneous vaginal birth (p = 0.7) in groups A and B, respectively.
In accordance with the method of management (Table 4), we found the highest rate of ECS among patients with confirmed hypotrophy after delivery (44.6% vs 30.9% in the unconfirmed group; p = 0.04). That mode of delivery was also most frequent among mothers from group A. The percentage of induced labor cases was the highest in patients with unverified SGA and equaled 58% vs 38.5% in group A (p = 0.0208). Both groups are characterized by a similar percentage of elective procedures (induction and cesarean section altogether), measured at 83.1% (A) and 88.9% (B) with a p-value of 0.3408. A decidedly less frequently reported method of delivery in the studied group was spontaneous vaginal delivery, without a significant difference between groups A and B (16.9% vs 11.1%; p = 0.3408).
Expectant management in both groups led to worse perinatal outcomes than elective procedures performed to prevent fetal complications.
From a different perspective, dividing the groups into severe (below the 3 rd percentile) and mild (3 rd -9.9 th percentile) hypotrophy, serious complications occurred in 62% and 38% of newborn babies, respectively (Fig. 1) . 
Discussion
In this study, the estimated positive predictive value of ultrasound examination in the recognition of SGA during late pregnancy was 44.5%. This data is similar to the findings from a large population-based study on French pregnant women, where 1/2 of all infants suspected of FGR were not confirmed after delivery. 17 To the best of our knowledge, there are limited studies which ex post facto evaluate the correlation between different variables and their influence on making a correct or false positive diagnosis of SGA. The available clinical data is very limited and precludes any reliable conclusion in that area.
According to our study, mothers with SGA babies confirmed after delivery were significantly older than those with the false positive diagnosis (mean age of 32.5 years in group A; p = 0.0015). Early motherhood is considered a risk factor for lower birth weight in newborns, while advanced age seems to increase the frequency of SGA only in primiparous women. 18, 19 Apart from that, a longer duration of pregnancy and advanced gestational age at the time of delivery (36.9 ±2.55 weeks vs 34.9 ±3.80 weeks in confirmed cases) correlate with a higher incidence of incorrect antenatal diagnoses (p = 0.0317).
Interesting conclusions can be drawn when it comes to the comparison of the positive predictive value of ultrasound examination with the mothers' BMI values at the beginning of pregnancy.
Underweight mothers (BMI <18.5 kg/m²) correlate with nearly 5 times more frequent overdiagnosis of SGA in comparison to BMI values between 18.5 kg/m² and 25 kg/m², and >25 kg/m² (11% of correct diagnoses vs 49% and 46% in the remaining groups, respectively; p = 0.0051). In that group, only 11% of the fetuses suspected antenatally of being SGA were confirmed as hypotrophic fetuses after birth. Lower maternal initial BMI values seem to be associated with impaired EFW assessment. The phenomenon described above may be related to the influence of certain constitutive factors.
There is substantial evidence in the literature which proves that petite women, especially those underweight before pregnancy, give birth to smaller babies. 20 On the other hand, a recently published vast meta-analysis provides evidence that short maternal stature and chronic malnutrition, especially in developing countries, contribute to a higher incidence of SGA. 21 It is hard to draw clear conclusions if that diagnosis is connected to inter-subject variability or the damaging influence of exogenous factors.
More often, the overdiagnosis of SGA babies in women with lower BMI before pregnancy seems to confirm that most of those cases are likely associated with genetic factors rather than pathological intrauterine growth retardation. Such hypotheses were also presented by previous researchers, who concluded that a generational transmission of SGA is possible. 22 In this situation, it is worth considering the usefulness of customized charts during ultrasound examination in pregnant women, rather than standard population-based ones. 23 It has been proven that for SGA suspected antenatally, using customized growth potential is able to identify substantially more pregnancies at risk for adverse outcomes than the currently used national standard for fetal growth. 24 Recently, the authors of a multi-center project called INTERGROWTH-21 st , which included 13,108 pregnant women, created fetal growth curves with regard to 5 basic ultrasound measurements. The utility of those charts was positively evaluated in different populations and it may offer precise assessment of intrauterine fetal growth before the customized charts become available. 25 Such factors as the mother's age, the duration of pregnancy, parity, or the time elapsed since the previous delivery seem not to correlate with a true or false positive diagnosis of SGA.
The most severe complication in the course of pregnancy -intrauterine death -occurred 2 times in group A, while it was not reported among patients from group B. However, the risk of intrauterine death was not significantly correlated with any pathologies during the course of pregnancy, including IUGR (p = 0.196), though this may result from the small sample size.
Aware of fetal complications, obstetricians decide to induce labor, while this procedure is not without consequences.
The multi-center randomized trial, DIGITAT, comparing both types of managements (induction and expectant monitoring), provided similar efficacy regarding perinatal outcomes. Despite this, the researchers found that induced labor seems to be a more rational method of management which reduces the risk of stillbirth and newborn morbidity. 26 In this study, the estimated percentage of ECSs among true-positives amounted to 44.6% and was twice as high as that from the previously described study on the French population (44.6% vs 23.8%), while the ECSs in false-positives were carried out with similar frequency (30.9% vs 28.4% in the French study). 17 Stricter indications for elective procedures and more appropriate recognition of FGR could prevent the side effects of unnecessary medical interventions in the future.
In the context of the final neonatal outcomes, the current study shows that expectant management can increase the percentage of neonatal complications; the best indicators of that are the number of neonates hospitalized in the NICU and neonatal deaths. Elective delivery -labor induction or ECS -despite the risk of these invasive procedures, could minimize adverse neonatal outcomes in patients with suspected fetal hypotrophy.
In contrast, previous longitudinal studies on pregnant women with suspected FGR suggest that a higher incidence of obstetric interventions does not entail demonstrable positive effects upon short-term neonatal outcomes. 27 Moreover, induction of labor seems to be associated with a higher rate of adverse neonatal outcomes. 28, 29 Evidence on the best management strategy for at term IUGR, when it comes to perinatal outcomes, is still lacking. 30 This difficult decision between elective procedure and expectant management should always be taken by an experienced obstetrician, with careful consideration of the advantages and disadvantages of both methods. It is hard to draw an explicit conclusion about which form of management could be better, and in each case, all conditions should be individually assessed.
There are several limitations of this study that should be considered along with the results.
First of all, the selected study group is from a single-center study, conducted in a tertiary medical center unit. At baseline, most patients underwent more than 1 diagnosis, which makes it hard to compare them to the standard population.
On the other hand, the cohort of patients with confirmed SGA after delivery accounted for only 65 cases. In such limited study group, it is hard to draw unmistakable correlations between different factors and their influence on the occurrence of SGA. More research on a larger group of patients with confirmed SGA is required.
Secondly, as mentioned before, the measurements which were the basis for diagnosing SGA were taken by several ultrasonography technicians. Aberrations caused by human error cannot be excluded, and they may impact the reproducibility of the results between sequential ultrasound examinations.
The assessment of SGA was set only based on EFW below the 10 th percentile. On the other hand, there are some studies which prove that evaluating artery flow with fetal biometry aids in identifying the babies at risk of IUGR. Such a procedure may decrease the number of antenatal false positive diagnoses of SGA in the future.
Conclusions
Creating customized percentile charts which could be correlated with other additional parameters, such as the patient's BMI, may decrease the overdiagnosis of SGA when using ultrasound imaging in the future. Stricter indications for the induction of labor would prevent unnecessary medical procedures and their side effects. However, expectant management leads to worse perinatal outcomes, defined as a higher rate of neonate death or required NICU treatment, than elective procedures.
With the goal of better neonatal outcomes, it seems more rational to choose elective management in patients suspected of being SGA, indeed, if that diagnosis is characterized by sufficient reliability.
